Clinical trial · Interventional
The Effect of Double Injection Erector Spinae Plane Block on Postoperative Pain Following Breast Surgery
NCT03415646CI-TRIAL-00032004completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Postoperative analgesia in breast surgery is a difficult and overworked issue due to extensive surgery and complex innervation of the breast. Erector spinae plane block (ESB) is a new defined regional anesthesia technique for thoracic analgesia.Main purpose of this study was to evaluate the analgesic effect of ultrasound guided double injection ESB in breast surgery.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Postoperative Pain | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Erector Spinae Plane Block | Other | — | UNRESOLVED |
| Intravenous Morphine patient controlled analgesia device | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Block Group
- description
- Erector Spinae Plane Block administered group
- interventionNames
- Other: Erector Spinae Plane Block
- Device: Intravenous Morphine patient controlled analgesia device
- type
- SHAM_COMPARATOR
- label
- Control Group
- description
- Control group
- interventionNames
- Device: Intravenous Morphine patient controlled analgesia device
Primary outcomes (1)
- measure
- Morphine consumption
- timeFrame
- 24 hour postoperatively
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * 25-70 years of age * ASA I-II * Undergoing elective breast cancer surgery Exclusion Criteria: * obesity (body mass index \>35 kg/m2) * infection of the skin at the site of needle puncture area * patients with known allergies to any of the study drugs * coagulopathy * recent use of analgesic drugs.
References
Publications (0)
Data not yet available
No reference posted for this study.